Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
2,856,635
-
Share change
-
-112,075
-
Total reported value
-
$29,787,474
-
Price per share
-
$10.44
-
Number of holders
-
62
-
Value change
-
-$1,694,380
-
Number of buys
-
20
-
Number of sells
-
24
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q2 2024
As of 30 Jun 2024,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,856,635 shares.
The largest 10 holders included
One Capital Management, LLC, Raymond James Financial Services Advisors, Inc., Portland Global Advisors LLC, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., Lido Advisors, LLC, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, Stratos Wealth Partners, LTD., and OPPENHEIMER ASSET MANAGEMENT INC..
This page lists
62
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.